Thursday, September 30, 2021 8:15:48 PM
So You think AGN should wait until we see Auz data to expand the work with Ifenprodil / CC?? Really.
The FDA will review the applications and data that AGN presents. That apparently is 'in process' for a Phase 2 Chronic Cough CT that will be 'Powered' to meet sig stat'.
I never go 'all-in'. I'm an opinionated piss-ant BTH (x-BLO) poster on this obscure MB. Buying small and steadily now. Certainly not doing $10M deals.
I enjoy the banter. This OTC stuff is speculative 'semi-informed' gambling. hacax is doing fine but moving to habdx lately. Been out of BA for years and OI-others for a decade +.
The dilution had sure damaged past BTH holders but where is some thing better for the current PPS.?. Stupid to sell here. IMO. ..GLTA...
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM